Brilliant results and Stan Perron Charitable Foundation is paying for all test results up to a clinical trial on infants.
Zero competition in the HIE space and results have been far superior to the current method of hypothermia.
I wonder at what stage we can apply for the FDA Paediatric Review Voucher and if granted would we sell it for an estimate of $100 million or use it to fastrack ARG 007 FDA approval for HIE applications.
Ann: Preclinical HIE Study - ARG007 Effective Stand-Alone Therapy, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
-0.010(1.30%) |
Mkt cap ! $98.63M | |||
| Open | High | Low | Value | Volume |
| 78.0¢ | 78.0¢ | 76.0¢ | $22.19K | 29.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 75.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 14683 | 5 |
View Market Depth
| Last trade - 10.29am 04/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |